Citation Impact
Citing Papers
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
1978
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Infection, inflammation, height, and longevity
2005 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
A Prospective Study of Renal Stone Recurrences
1984
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
1999
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
1992 Standout
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 Standout
Lipids, risk factors and ischaemic heart disease
1996
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
1998 Standout
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
The metabolic syndrome
2010 Standout
Development and validation of brief measures of positive and negative affect: The PANAS scales.
1988 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Huge variation in Russian mortality rates 1984–94: artefact, alcohol, or what?
1997
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study
2000 Standout
Alcohol and public health
2005 Standout
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
2000 Standout
Kidney function and discrimination of cardiovascular risk in middle‐aged men
2009
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: The African-American study of kidney disease and hypertension pilot study1
1997
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Snoring and Systemic Hypertension—an Epidemiological Study
1987
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Socioeconomic Inequalities in Health in 22 European Countries
2008 Standout
The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox: Table 1
2000
Renal function: the Cinderella of cardiovascular risk profile
2001
A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones
1993 Standout
Funnel plots for detecting bias in meta-analysis
2001 Standout
Alcohol and sudden cardiac death
1992
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
1996 Standout
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
Essential arterial hypertension and stone disease
1999
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
1992
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men
2007
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test.
1994 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Mechanisms of Bone Metastasis
2004 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic Acid
1988
Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study
1996
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
1994
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis
2003
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Triglycerides and the Risk of Coronary Heart Disease
2006
Renal stone epidemiology: A 25-year study in Rochester, Minnesota
1979 Standout
Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies
1996 Standout
Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease
2001
Polymorphism of apolipoprotein E
1979
Subjective well-being: Three decades of progress.
1999 Standout
The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity
1998
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Health complaints, stress, and distress: Exploring the central role of negative affectivity.
1989 Standout
Independent Pathways for Secretion of Cholesterol and Apolipoprotein E by Macrophages
1983 StandoutScienceNobel
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
1981 StandoutNobel
Familial Dysbetalipoproteinemia: New Aspects of Pathogenesis and Diagnosis
1982
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of Hans Hedstrand being referenced
ACE Inhibition Preserves Renal Function Better thanbT-blockade in the Treatment of Essential Hypertension
1995
Serum Lipoprotein Concentration and Composition in Healthy 50-year-old Men
1976
Inheritance of type-III hyperlipoproteinemia. Lipoprotein patterns in first-degree relatives
1977
EPIDEMIOLOGY OF RENAL STONES IN A MIDDLE‐AGED MALE POPULATION
1975
Calcium, Phosphate and Albumin in Serum
1977
Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen
1977
A study of middle-aged men with particular reference to risk factors for cardiovascular disease.
1975
Alcohol intemperance and sudden death.
1987
Renal Stones and Coronary Heart Disease
1976
Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris
1985
The Early Serum Insulin Response to Intravenous Glucose in Patients with Decreased Glucose Tolerance and in Subjects with a Familial History of Diabetes Mellitus
1976
The Early Serum Insulin Response to Intravenous Glucose in Patients with Decreased Glucose Tolerance and in Subjects with a Familial History of Diabetes Mellitus
1976